Alltrna

Alltrna is a biotechnology company developing transfer RNA (tRNA) therapeutics to treat genetic diseases caused by nonsense mutations and other protein expression deficiencies. The company's platform focuses on engineering tRNA molecules to restore functional protein production in cells where disease-causing mutations lead to premature stop codons or inadequate protein levels. By delivering modified tRNAs, Alltrna aims to enable cells to read through nonsense mutations and produce full-length, functional proteins. This approach has potential applications across numerous genetic disorders where protein restoration could provide therapeutic benefit. Founded by Flagship Pioneering, Alltrna is working to unlock tRNA biology as a new therapeutic modality, addressing diseases that have been difficult to treat with conventional approaches. The company represents a novel approach to treating genetic diseases at the translational level.